Project Grant R01CA301168
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$547K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Washington, DC, USA
Similar Awards
This $1,793,830 federal Project Grant award was granted by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The primary recipient, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI), will conduct a cluster-randomized trial across 20 primary care clinics serving communities with at least 25% Spanish-speaking patient populations. The study aims to compare the impact of a Normalization Process Theory-guided...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research program) totaling $224,099 will support research at the University of California, San Diego (UCSD) to develop a targeted colorectal cancer (CRC) screening strategy for adults aged 45-49. The key objectives are to: Characterize the acceptability of CRC screening in this age group through a pilot trial and surveys/interviews to identify effective implementation strategies. Conduct a...
This Federal Project Grant award, with an ID of K08CA285952, was provided by the National Cancer Institute under the Cancer Research Manpower (CFDA 93.398) program. The award, valued at $197,640, aims to develop implementation strategies with a focus on equity to initiate colorectal cancer (CRC) screening in previously unscreened individuals aged 45 to 54 at the Codman Square Health Center, a predominantly Black community health center in Boston. The key products and services to be delivered...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) aims to develop and evaluate a comprehensive intervention to improve cervical cancer screening and follow-up among underserved populations, including urban inner-city Blacks/Haitians, Hispanic immigrants, and Hawaiian Natives/Pacific Islanders. The $753,446 award to Boston Medical Center Corporation will fund the adaptation of a successful HPV vaccination intervention model to address...
The National Cancer Institute (NCI) awarded a $696,852 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Harvard T.H. Chan School of Public Health. The grant will fund a 5-year research project to optimize a mobile messaging intervention for promoting colorectal cancer (CRC) screening among patients at community health centers (CHCs). The project aims to increase CRC screening rates, which are below national averages at CHCs, by leveraging text message...
The Project Grant award R15CA294297, titled "Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women," is funded by the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395). The $477,869 award aims to develop an evidence-based cervical cancer intervention for Black women, with components specifically targeted for African American women and Black African immigrant women. The project seeks to identify...
This $2,282,687 federal Project Grant award was made by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant supports a multi-year research program to understand how different forms of care integration (structural, functional, normative, interpersonal, and process) in oncology practices are associated with quality of care and patient outcomes, including for marginalized populations. The research program involves four interrelated...
This $269,942 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports the development and pilot testing of a community health worker (CHW) intervention to improve lung cancer screening uptake among Black and Hispanic communities served by Baystate Health's community health centers. The key products/services to be delivered include: Jointly "transcreating" the CHW intervention with a community advisory board to address barriers to...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Research Manpower (CFDA 93.398) program, provides $192,433 to the University of Alabama at Birmingham (UAB) to pilot an implementation strategy for mainstream genetic testing in colorectal cancer (CRC) patients. The goal is to increase the use of mainstream genetic testing (MGT) in CRC by characterizing barriers to implementing MGT and piloting a multi-level implementation strategy to address these barriers....
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund a research project titled "Interventions to Decrease Cancer Information Avoidance." The total funding amount is $637,596 over the award period from April 4, 2025 to March 31, 2030. The project aims to develop and test a video-based intervention strategy designed to reduce defensive avoidance of colorectal cancer information and increase engagement with...